Have You experienced a side effect?
and Vote

Yes, Severe
Yes, Moderate
Yes, Minor
No
Discuss Results
1.5 million people annually are harmed from drug errors. Side Effects Reported Today:

Don't Risk Your Health!
Ask a Health Expert Now


PERICARDIAL EFFUSION MALIGNANT side effect

What is PERICARDIAL EFFUSION MALIGNANT ?
Help Community - Describe Your Side Effect   Search FDA Side Effects   Ask Health Expert   PERICARDIAL EFFUSION MALIGNANT and Recently Reported Side Effects   PERICARDIAL EFFUSION MALIGNANT and 15 most Active Side Effect polls   PERICARDIAL EFFUSION MALIGNANT and featured health surveys   Substances toxic to Health   Recent Hospital reviews   Comments about Side Effects   Hospital Quality reviews   Homecare Quality reviews
Health Expert

A Health Expert wants to answer your question.

Please provide details below.



Drugs associated with PERICARDIAL EFFUSION MALIGNANT

LAPATINIB  LAPATINIBLET  TARCEVA  


Lapatiniblet Side Effects Report #5640116-5
Physician from AUSTRIA reported LAPATINIBLET problem on Feb 11, 2008. Female patient, 55 years of age, weighting 173.1 lb, was diagnosed with breast cancer metastatic and was treated with LAPATINIBLET. After drug was administered, patient experienced the following problems/side effects: disease progression, pericardial effusion malignant, . LAPATINIBLET dosage: unknown. During the same period patient was treated with CAPECITABINELET. Patient was hospitalized. Patient recovered.

Lapatinib Side Effects Report #5645320-8
LAPATINIB problem was reported by a Physician from AUSTRIA on Feb 26, 2008. Female patient, 55 years of age, weighting 173.5 lb, was treated with LAPATINIB. After drug was administered, patient experienced the following problems/side effects: dyspnoea, pericardial effusion malignant, pulmonary embolism, . LAPATINIB dosage: 1250MG PER DAY. During the same period patient was treated with CAPECITABINE. Patient was hospitalized. Patient recovered.

Tarceva Side Effects Report #5565851-9
Pharmacist from GERMANY reported TARCEVA problem on Dec 05, 2007. Male patient was diagnosed with non-small cell lung cancer and was treated with TARCEVA. After drug was administered, patient experienced the following problems/side effects: condition aggravated, pericardial effusion malignant, . TARCEVA dosage: unknown. Patient recovered.

PatientsVille.com does not provide medical advice, diagnosis or treatment. The information contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments.


Thank you for visiting Patientsville.com. We hope you found our information about PERICARDIAL EFFUSION MALIGNANT side effects helpful. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting Patientsville.net. Hope you enjoyed finding information on medications and found answers to Your Questions about PERICARDIAL EFFUSION MALIGNANT